BDSX FY 2024 Earnings — Biodesix, Inc. Revenue & Financial Results | Market Cap Arena

BDSXBiodesix, Inc.

$151M

FY 2024 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$71M+45.3% YoY

Gross Profit

$56M78.2% margin

Operating Income

-$34M-48.4% margin

Net Income

-$43M-60.2% margin

EPS (Diluted)

$-6.60

Cash Flow

Operating Cash Flow

-$49M

Free Cash Flow

-$52M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$97M

Total Liabilities

$76M

Stockholders' Equity

$21M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$71M	$49M	+45.3%
Gross Profit	$56M	$36M	+54.5%
Operating Income	-$34M	-$41M	+16.6%
Net Income	-$43M	-$52M	+17.7%